Since therapeutic response of malignant glioma to TMZ is known to be highly correlated with MGMT promoter methylation and a subsequent decrease in MGMT protein expression [5,21], we performed Western blotting of MGMT protein in 19 out 20 cell cultures tested in our initial drug screening (Figure 2C). The gene discussed is MGMT; the disease is malignant glioma.